Abdel Almanfi, MD, FACC, FSCAI (@almanfi_cardio) 's Twitter Profile
Abdel Almanfi, MD, FACC, FSCAI

@almanfi_cardio

TAVR Proctor | Structural Heart Interventional cardiologist | EndoVascular/Coronary Interventions| Baylor St. Luke’s | trained @Texas_Heart | ⚽️ ♟️ | 🇱🇾 🇺🇸

ID: 254736198

linkhttps://houstoncardiovascularcare.com calendar_today19-02-2011 22:17:49

11,11K Tweet

12,12K Takipçi

897 Takip Edilen

Abdel Almanfi, MD, FACC, FSCAI (@almanfi_cardio) 's Twitter Profile Photo

So glad to co-moderate this live case from Brazil 🇧🇷 as part of the Global Structural summit this past weekend. Excellent case selection and performance by great team with fantastic clinical outcome. Medtronic

Abdel Almanfi, MD, FACC, FSCAI (@almanfi_cardio) 's Twitter Profile Photo

Moderating 4 Live TAVR Evolut cases from Australia 🇦🇺, Taiwan 🇹🇼, Brazil 🇧🇷 & Argentina 🇦🇷 was a great fun alongside Antonious Attallah, MD, FACC, FSCAI In-person discussions & debates about #TAVR latest data & best practices among implanters from different 12 nations (aside from US) Thanks to

Moderating 4 Live TAVR Evolut cases from Australia 🇦🇺, Taiwan 🇹🇼, Brazil 🇧🇷 &amp; Argentina 🇦🇷 was a great fun alongside <a href="/AntoniousAttall/">Antonious Attallah, MD, FACC, FSCAI</a> 
In-person discussions &amp; debates about #TAVR latest data &amp; best practices among implanters from different 12 nations (aside from US) 
Thanks to
NEJM (@nejm) 's Twitter Profile Photo

RESHAPE-HF trial: Among patients with at least moderate functional mitral regurgitation, transcatheter valve repair led to a lower rate of heart failure events during 24 months and better health status at 12 months than medical therapy alone. nej.md/477rpaC #ESCardio

RESHAPE-HF trial: Among patients with at least moderate functional mitral regurgitation, transcatheter valve repair led to a lower rate of heart failure events during 24 months and better health status at 12 months than medical therapy alone. nej.md/477rpaC 

#ESCardio
RTHahnMD (@hahn_rt) 's Twitter Profile Photo

RESHAPE-HF2 shows no impact on mortality but significant reduction in HFH and improvement in KCCQ. All call for a larger trial to confirm MTEER for lower risk and lower MR severity. #ESC2024

American College of Cardiology (@accintouch) 's Twitter Profile Photo

TEER was as effective as surgery for treating patients with secondary #vhdMR, according to findings from the MATTERHORN trial presented at #ESCCongress Researchers also noted that TEER had a better safety profile compared with surgical intervention. Read more:

Abdel Almanfi, MD, FACC, FSCAI (@almanfi_cardio) 's Twitter Profile Photo

This study adds to our understanding. In women with small annulus, the best option is not surgery, not TAVR with balloon-expandable valve. It’s TAVR using Evolut self-expanding valve as shown in SMART trial.

Wail AlkashkariFSCAI,FPICSوائل القشقرى🇸🇦🇨🇦🇺🇲 (@alkashkariwail) 's Twitter Profile Photo

يقول النبي ﷺ من لا يشكر الناس لا يشكر الله " اتقدم بجزيل الشكر والتقدير والعرفان لأخي د مبارك الدوسري وجميع الزملاء الكرام بمركز القلب بمدينة الملك سعود الطبية التجمع الصحي الاول بالرياض على إغداقي وتشريفي بجائزة تقدير وتكريم على ماقمت به في خدمة جمعية قسطرة القلب السعودية

Cardiovascular Research Foundation (@crfheart) 's Twitter Profile Photo

🚀 Take your career to new heights at the #TCT2024 Nurse and Technologist Symposium! ✨ Discover the latest advances and delve into the dynamics of patient-centered care at this full-day program. Secure your spot now! 🔗 tct2024.crfconferences.com/nurse-and-tech… #nurses #cathlab #cathlabnurses